» Articles » PMID: 22962684

Autotaxin Through Lysophosphatidic Acid Stimulates Polarization, Motility, and Transendothelial Migration of Naive T Cells

Overview
Journal J Immunol
Date 2012 Sep 11
PMID 22962684
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Blood-borne lymphocytes home to lymph nodes by interacting with and crossing high endothelial venules (HEVs). The transendothelial migration (TEM) step is poorly understood. Autotaxin (ATX) is an ectoenzyme that catalyzes the conversion of lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA), a bioactive lipid and a close relative of sphingosine 1-phosphate. HEVs produce and secrete ATX into the blood. A prior study implicated ATX in the overall homing process, but the step in which it functions and its mechanism of action have not been defined. In this article, we show that HA130, an inhibitor of the enzymatic activity of ATX, slows T cell migration across lymph node HEVs in vivo. Ex vivo, ATX plus LPC or LPA itself induces the polarization of mouse naive T cells and stimulates their motility on an ICAM-1 substratum. Under physiologic shear conditions in a flow chamber, LPA or ATX/LPC strongly enhances TEM of integrin-arrested T cells across an endothelial monolayer. HA130 blunts the TEM-promoting activity of ATX, paralleling its in vivo effects. T cells possess Mn(+2)-activatable receptors for ATX, which are localized at the leading edge of polarized cells. ATX must bind to these receptors to elicit a maximal TEM response, providing a mechanism to focus the action of LPA onto arrested lymphocytes in flowing blood. Our results indicate that LPA produced via ATX facilitates T cell entry into lymph nodes by stimulating TEM, substantiating an additional step in the homing cascade. This entry role for LPA complements the efflux function of sphingosine 1-phosphate.

Citing Articles

Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.

Laface C, Ricci A, Vallarelli S, Ostuni C, Rizzo A, Ambrogio F Int J Mol Sci. 2024; 25(14).

PMID: 39062979 PMC: 11277072. DOI: 10.3390/ijms25147737.


The Emerging Role of LPA as an Oncometabolite.

Karalis T, Poulogiannis G Cells. 2024; 13(7.

PMID: 38607068 PMC: 11011573. DOI: 10.3390/cells13070629.


Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis.

Petersen-Cherubini C, Murphy S, Xin M, Liu Y, Deffenbaugh J, Jahan I Eur J Immunol. 2023; 54(1):e2350561.

PMID: 37850588 PMC: 10843518. DOI: 10.1002/eji.202350561.


Targeting metabolism in aortic aneurysm and dissection: from basic research to clinical applications.

Wang Q, Yesitayi G, Liu B, Siti D, Ainiwan M, Aizitiaili A Int J Biol Sci. 2023; 19(12):3869-3891.

PMID: 37564200 PMC: 10411465. DOI: 10.7150/ijbs.85467.


Phosphatidic Acid Stimulates Lung Cancer Cell Migration through Interaction with the LPA1 Receptor and Subsequent Activation of MAP Kinases and STAT3.

Gomez-Larrauri A, Gangoiti P, Camacho L, Presa N, Martin C, Gomez-Munoz A Biomedicines. 2023; 11(7).

PMID: 37509443 PMC: 10376810. DOI: 10.3390/biomedicines11071804.


References
1.
Sanchez-Madrid F, Serrador J . Bringing up the rear: defining the roles of the uropod. Nat Rev Mol Cell Biol. 2009; 10(5):353-9. DOI: 10.1038/nrm2680. View

2.
Jansen S, Stefan C, Creemers J, Waelkens E, Van Eynde A, Stalmans W . Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J Cell Sci. 2005; 118(Pt 14):3081-9. DOI: 10.1242/jcs.02438. View

3.
Zhang H, Xu X, Gajewiak J, Tsukahara R, Fujiwara Y, Liu J . Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. Cancer Res. 2009; 69(13):5441-9. PMC: 3446773. DOI: 10.1158/0008-5472.CAN-09-0302. View

4.
Zhao J, He D, Berdyshev E, Zhong M, Salgia R, Morris A . Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways. Biochem J. 2011; 439(1):45-55. PMC: 3674636. DOI: 10.1042/BJ20110274. View

5.
Lamb T, Graham A, Petrie A . T testing the immune system. Immunity. 2008; 28(3):288-92. DOI: 10.1016/j.immuni.2008.02.003. View